Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2010 2
2014 7
2015 6
2016 4
2017 2
2018 9
2019 16
2020 12
2021 8
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
The immune system and cancer evasion strategies: therapeutic concepts.
Muenst S, Läubli H, Soysal SD, Zippelius A, Tzankov A, Hoeller S. Muenst S, et al. Among authors: laubli h. J Intern Med. 2016 Jun;279(6):541-62. doi: 10.1111/joim.12470. Epub 2016 Jan 8. J Intern Med. 2016. PMID: 26748421 Free article. Review.
Targeted glycan degradation potentiates the anticancer immune response in vivo.
Gray MA, Stanczak MA, Mantuano NR, Xiao H, Pijnenborg JFA, Malaker SA, Miller CL, Weidenbacher PA, Tanzo JT, Ahn G, Woods EC, Läubli H, Bertozzi CR. Gray MA, et al. Among authors: laubli h. Nat Chem Biol. 2020 Dec;16(12):1376-1384. doi: 10.1038/s41589-020-0622-x. Epub 2020 Aug 17. Nat Chem Biol. 2020. PMID: 32807964 Free PMC article.
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.
Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier-Pfistershammer K, Maurer-Granofszky M, Roka F, Penz T, Bock C, Zhang G, Herlyn M, Glatz K, Läubli H, Mertz KD, Petzelbauer P, Wiesner T, Hartl M, Pickl WF, Somasundaram R, Steinberger P, Wagner SN. Griss J, et al. Among authors: laubli h. Nat Commun. 2019 Sep 13;10(1):4186. doi: 10.1038/s41467-019-12160-2. Nat Commun. 2019. PMID: 31519915 Free PMC article.
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.
Berner F, Bomze D, Diem S, Ali OH, Fässler M, Ring S, Niederer R, Ackermann CJ, Baumgaertner P, Pikor N, Cruz CG, van de Veen W, Akdis M, Nikolaev S, Läubli H, Zippelius A, Hartmann F, Cheng HW, Hönger G, Recher M, Goldman J, Cozzio A, Früh M, Neefjes J, Driessen C, Ludewig B, Hegazy AN, Jochum W, Speiser DE, Flatz L. Berner F, et al. Among authors: laubli h. JAMA Oncol. 2019 Jul 1;5(7):1043-1047. doi: 10.1001/jamaoncol.2019.0402. JAMA Oncol. 2019. PMID: 31021392 Free PMC article. Clinical Trial.
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
Alborelli I, Leonards K, Rothschild SI, Leuenberger LP, Savic Prince S, Mertz KD, Poechtrager S, Buess M, Zippelius A, Läubli H, Haegele J, Tolnay M, Bubendorf L, Quagliata L, Jermann P. Alborelli I, et al. Among authors: laubli h. J Pathol. 2020 Jan;250(1):19-29. doi: 10.1002/path.5344. Epub 2019 Oct 24. J Pathol. 2020. PMID: 31471895 Free PMC article.
Cancer Immunotherapy.
Pearce OMT, Läubli H. Pearce OMT, et al. Among authors: laubli h. Glycobiology. 2018 Sep 1;28(9):638-639. doi: 10.1093/glycob/cwy069. Glycobiology. 2018. PMID: 30084981 No abstract available.
Selectins promote tumor metastasis.
Läubli H, Borsig L. Läubli H, et al. Semin Cancer Biol. 2010 Jun;20(3):169-77. doi: 10.1016/j.semcancer.2010.04.005. Epub 2010 May 7. Semin Cancer Biol. 2010. PMID: 20452433 Free article. Review.
61 results